These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Predictability of response to endocrine ablation in breast cancer.
    Author: Criss WE, Bland KI, O'Leary JP.
    Journal: South Med J; 1975 Jun; 68(6):714-6. PubMed ID: 166448.
    Abstract:
    Carcinoma of the breast remains the most common and most frequently lethal form of cancer in women. In far-advanced disease, endocrine manipulation remains the major modality of treatment. Recent advances have shown that approximately 40% of breast cancers contain estradiol receptors in their cytoplasm. The presence or absence of these receptors is a good indicator of whether or not the patient will respond to endocrine ablation.
    [Abstract] [Full Text] [Related] [New Search]